drugset / Trial / NCT00051753

Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media

NCT00051753

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to demonstrate non-inferiority of levofloxacin compared with amoxicillin/clavulanate on the clinical response at the end of therapy in infants and children who have recurrent and/or persistent acute otitis media.

Timeline

Start
2002-11
Primary completion
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule 10 mg/kg Oral
Subject amoxicillin/clavulanate Unknown 45 mg/kg Oral

Indications